Completed
Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
NCT00392288
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- sanofi-aventis, US Bridgewater, New Jersey, United States
- Sanofi-Aventis Hungaria Budapest, Hungary
- Sanofi-Aventis México, Mexico
- sanofi-aventis Poland Warsaw, Poland